메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14

[ 메디채널 김갑성 기자 ] EVM14 becomes Everest Medicines' internally developed therapeutic mRNA cancer vaccine to receive IND approvals from both China's National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, is developed based on Everest Medicines' proprietary mRNA platform. It is formulated with mRNA encoding 5 tumor-associated antigens (TAAs) and is designed to treat various squamous cell carcinomas. In preclinical studies, EVM14 demonstrated the ability to induce immune memory and prevent tumor
- 김갑성 기자
- 2025-10-13 08:47
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, which supports once-monthly subcutaneous (SQ) dosing in humans. - In head-to-head NHP studies, drug exposures of ASC35 intravenous (I.V.) and SQ administration were approximately 80% and 70% greater than tirzepatide I.V. and SQ administration, respectively. - ASC35 was approximately 4-fold more potent than tirzepatide for both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR) in vitro. - ASC35 demonstrated approximately 71% greate
- 김갑성 기자
- 2025-10-13 08:10
Reach Surgical's OMNIBOT Performs First Urology Robotic Telesurgeries in Latin America

Advancing regional collaboration and surgeon training in remote robotic-assisted surgery SINGAPORE, Oct. 13, 2025 -- Reach Surgical, the Surgical Solutions division of Genesis MedTech, has facilitated the completion of two robotic telesurgeries using its OMNIBOT robotic-assisted system. Operating from Reach Surgical Institute (RSI) in Santiago, Dr. Roberto Vilches and Dr. Marcelo Kerkebe remotely performed a radical prostatectomy and a partial nephrectomy on patients at Meds Medical Center. These procedures mark an important milestone in advancing robotic t
- 김갑성 기자
- 2025-10-13 08:00
Atelier Expressions、フランス磁器メーカーLimoges JL Coquetの買収を発表

リモージュ（フランス）, 2025年10月13日 -- 1824年創業の象徴的なリモージュ磁器メーカーJL Coquetは、TVS Venu International Holdings Pte Ltdが新たに設立したAtelier Expressionsへの参画により、歴史の新たな章を開きます。シンガポールに拠点を置くAtelier Expressionsは、卓越した企業と伝統的技術の継承を推進することを目的としています。この戦略的提携は、特に白磁の卓越性で知られる同メーカーにとって大きな前進となります。これは国際展開と職人技の振興への取り組みの一環であり、専門技術の継承とメーカー内での雇用維持に重点を置いています。「JL Coquetの作品は時代を超えた伝統と完璧な職人技を体現しており、常に感銘を受けてきました」と、Atelier Expressionsのエグゼクティブ・ディレクター、Tara S. Venu氏は述べています。「今回の買収がもたらす可能性に胸を躍らせています。JL Coquetの精神は、卓越した品質と職人技を体現する企業に国際的な認知をもたらすという我々の志と完全に一致しています。」 Sébastien Cich氏がチームと製造スタッ
- 황정호 기자
- 2025-10-13 07:00
Osome Brings AI-Enabled Business Management Platform To UAE

AI simplifies business management for entrepreneurs Businesses freed from admin to focus on growth Osome to foster robust partner ecosystem SINGAPORE and HONG KONG, Oct. 13, 2025 -- Osome, the AI-enabled business management platform trusted by over 30,000 entrepreneurs globally, has officially entered the United Arab Emirates (UAE) with the opening of its office in Dubai. This move underscores Osome's commitment to alleviating financial and administrative burdens for founders while fostering a collaborative ecosystem of partners in the Middle East. It
- 황정호 기자
- 2025-10-13 05:30
Axaipay and E3 Middle East Entrepreneur Network Sign MoU to Empower UAE Entrepreneurs Expanding into Malaysia and Australia

KUALA LUMPUR, Malaysia, Oct. 13, 2025 -- Axai Digital Sdn. Bhd. ("Axaipay"), a leading Malaysian fintech company, and E3 Middle East Entrepreneur Network LLC FZ ("E3HUBS") have entered into a Memorandum of Understanding (MoU) during the Expand North Star 2025 event in Dubai, United Arab of Emirates (UAE). The collaboration aims to strengthen cross-border business collaboration and digital payment enablement for UAE-based entrepreneurs expanding into Malaysia and Australia. The signing ceremony was witnessed by Mr. Anuar Fariz Fadzil, Chief Executive Officer
- 황정호 기자
- 2025-10-13 03:57
Where Light Meets Shadow, Beauty Unveiled- Review of the 2nd Golden Panda Awards

CHENGDU, China, Oct. 12, 2025 -- In the golden September, in the homeland of pandas, the feast of light and shadow commenced once again, as the cultural rendezvous arrived as scheduled. On September 12th and 13th, the 2nd Golden Panda Awards were grandly held in Chengdu. Organized by the China Federation of Literary and Art Circles and the People's Government of Sichuan Province, and permanently hosted in Sichuan, the Golden Panda Awards consistently uphold the purpose of "promoting the building of a community with a shared future for mankind." They are dedicated to f
- 김장윤(JASON KIM) 기자
- 2025-10-12 10:00
LI-NING Welcomes Egor Dëmin to the Way of Wade Athlete Roster

NEW YORK, Oct. 11, 2025 -- LI-NING, a leading global sportswear and athletic lifestyle company, has signed Egor Dëmin to its roster of athletes under the Way of Wade basketball sub-brand, marking a new era for the company's international division. The partnership was announced by Mr. Li Ning, Founder of the LI-NING brand and the Group's Executive Chairman, together with Dwyane Wade, a 13-year LI-NING Brand Ambassador, during the unveiling of the new Way of Wade 12 in Macau, China, on Saturday night. It was attended by 150 media and influencers. "As we c
- 황정호 기자
- 2025-10-11 23:45
Lianlian DigiTech Signs Partnership with HKSAR Government as a Strategic Enterprise to Help Build a Modern Digital Payments Ecosystem

HONG KONG, Oct. 11, 2025 -- On October 9, the Office for Attracting Strategic Enterprises (OASES) of the Hong Kong Special Administrative Region (HKSAR) Government hosted a signing ceremony in Hong Kong for a new group of strategic enterprises. Witnessed by Paul Chan, Financial Secretary of the HKSAR, Lianlian DigiTech was named a strategic enterprise partner of the HKSAR Government. Xin Jie, CEO of Lianlian DigiTech, attended the ceremony on behalf of the company and signed an agreement with the HKSAR Government. According to OASES, this round of agreements covers 18 strategic
- 황정호 기자
- 2025-10-11 22:29
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001

CHENGDU, China, Oct. 11, 2025 -- C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of [177Lu]-BL-ARC001 Injection, the company's first radiopharmaceutical and a Class 1 innovative biologic. This milestone approval marks Biokin's entry into the fast-growing Radiopharmaceutical Drug Conjugate (RDC) field and reinforces its leadership in large-molecule oncology therapies (ADC/GNC/ARC). The company's flagship asset
- 김갑성 기자
- 2025-10-11 20:45

이전

81 82 83 84 85 86 87 88 89 90

많이 본 기사

최근기사

2025-11-02_SUN

2025-11-01_SAT

Manulife Hong Kong Supports 'Water Parade at Victoria Harbour' curated and organized by AllRightsReserved with Spectacular Drone Show Finale 23:49

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 02일 20시 20분